VEGFD and neoplasm: We found that tumor-secreted VEGFD binds to VEGFR2 on the surface of HEVs, impairs the lymphocyte homing function of HEVs, reduces the immune response of TDLNs, and provides favorable conditions for the arrival of tumor cells.